Jon Congleton Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 18 hours ago
Jon Congleton has an estimated net worth of at least $34.5 million*, as of yesterday. They own 780,051 shares of MLYS stock. They have sold 433,999 shares of MLYS stock since 2021, for an estimated $12.7 million.
Jon Congleton $MLYS SEC Form 4 Insider Trading
Jon Congleton has filed a total of 25 insider trades in $MLYS since 2021. Their most recent trade was a sale of 7,117 shares, made on Jan 12, 2026. Their largest trade was a sale of 112,275 shares, made on Nov 11, 2025. We estimate that they now own 780,051 shares of $MLYS, worth an estimated $21.8 million.
Insider Trading at $MLYS
There have been a total of 105 insider trades reported at $MLYS since 2021, with 7.8 million shares purchased and 3.1 million shares sold. The most active insider traders in $MLYS stock have been David Malcom Rodman, Jon Congleton, and Adam Scott Levy. The most recent trade was a sale of 2,171 shares reported by David Malcom Rodman (Chief Medical Officer), made on Mar 09, 2026.
History of Insider Stock Trades by Jon Congleton
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MLYS
|
Sale | 7,117 | Jan 12, 2026 | Jan. 13, 2026, 9:43 p.m. |
|
MLYS
|
Sale | 9,119 | Jan 12, 2026 | Jan. 13, 2026, 9:43 p.m. |
|
MLYS
|
Sale | 112,275 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 4,000 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 29,207 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 32,850 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 12,806 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 8,862 | Nov 11, 2025 | Nov. 13, 2025, 8:01 p.m. |
|
MLYS
|
Sale | 13,548 | Oct 13, 2025 | Oct. 15, 2025, 7:04 p.m. |
|
MLYS
|
Sale | 1,552 | Oct 13, 2025 | Oct. 15, 2025, 7:04 p.m. |
|
MLYS
|
Sale | 15,884 | Jul 11, 2025 | July 15, 2025, 5:02 p.m. |
|
MLYS
|
Sale | 15,319 | Apr 11, 2025 | April 15, 2025, 8:33 p.m. |
|
MLYS
|
Sale | 18,333 | Jan 13, 2025 | Jan. 15, 2025, 10:44 p.m. |
|
MLYS
|
Sale | 15,271 | Oct 11, 2024 | Oct. 15, 2024, 4:21 p.m. |
|
MLYS
|
Sale | 15,746 | Jul 11, 2024 | July 12, 2024, 4:36 p.m. |
|
MLYS
|
Sale | 17,766 | Jun 17, 2024 | June 20, 2024, 5:44 p.m. |
|
MLYS
|
Sale | 14,940 | Jun 20, 2024 | June 20, 2024, 5:44 p.m. |
|
MLYS
|
Sale | 16,607 | Jun 18, 2024 | June 20, 2024, 5:44 p.m. |
|
MLYS
|
Sale | 39,961 | Jun 13, 2024 | June 14, 2024, 6:15 p.m. |
|
MLYS
|
Sale | 16,607 | Jun 12, 2024 | June 14, 2024, 6:15 p.m. |
|
MLYS
|
Sale | 16,229 | Jun 14, 2024 | June 14, 2024, 6:15 p.m. |
|
MLYS
|
Purchase | 4,250 | Nov 22, 2023 | Nov. 27, 2023, 5:01 p.m. |
|
MLYS
|
Purchase | 2,250 | Sep 06, 2023 | Sept. 8, 2023, 8:49 a.m. |
|
MLYS
|
Purchase | 2,250 | Aug 17, 2023 | Aug. 21, 2023, 4:03 p.m. |
|
MLYS
|
Purchase | 2,000 | Aug 11, 2023 | Aug. 11, 2023, 7:11 p.m. |
$MLYS Executives and Stock Owners with Insider Trades
-
David Malcom Rodman, Chief Medical Officer
-
Jon Congleton, Chief Executive Officer
-
Adam Scott Levy, CFO and Secretary
-
Adam Scott Levy, CFO, Chief Bus. Off. and Secy.
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.